HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.

AbstractBACKGROUND AND PURPOSE:
Endocannabinoids and related N-acylethanolamines (NAEs) are involved in regulation of gut function, but relatively little is known as to whether inflammatory cytokines such as IFNγ affect their levels. We have investigated this in vitro using cultures of T84 colon cancer cells.
EXPERIMENTAL APPROACH:
T84 cells, when cultured in monolayers, differentiate to form adult colonic crypt-like cells with excellent permeability barrier properties. The integrity of the permeability barrier in these monolayers was measured using transepithelial electrical resistance (TEER). NAE levels were determined by ultra-performance liquid chromatography-tandem mass spectrometric analysis. Expression of the enzymes involved in NAE and 2-arachidonoylglycerol (2-AG) turnover were assessed with qPCR.
KEY RESULTS:
IFNγ treatment for 8 or 24 h increased levels of both endocannabinoids (anandamide and 2-AG) and the related NAEs. The treatment did not affect the rate of hydrolysis of either anandamide or palmitoylethanolamide by intact cells, and in both cases, fatty acid amide hydrolase (FAAH) rather than NAE-hydrolysing acid amidase (NAAA) was mainly responsible for the hydrolysis of these NAEs. IFNγ treatment reduced the TEER of the cells in a manner that was not prevented by inhibition of either FAAH or NAAA but was partially reversed by apical administration of the NAE palmitoylethanolamide.
CONCLUSION AND IMPLICATIONS:
IFNγ treatment mobilized endocannabinoid and related NAE levels in T84 cells. However, blockade of anandamide or NAE hydrolysis was insufficient to negate the deleterious effects of this cytokine upon the permeability barrier of the cell monolayers.
LINKED ARTICLES:
This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.
AuthorsMireille Alhouayek, Linda Rankin, Sandra Gouveia-Figueira, Christopher J Fowler
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 176 Issue 10 Pg. 1470-1480 (05 2019) ISSN: 1476-5381 [Electronic] England
PMID29313885 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 The British Pharmacological Society.
Chemical References
  • Amides
  • Arachidonic Acids
  • Endocannabinoids
  • Ethanolamines
  • Glycerides
  • N-acylethanolamines
  • Palmitic Acids
  • Polyunsaturated Alkamides
  • Ionomycin
  • palmidrol
  • Interferon-gamma
  • glyceryl 2-arachidonate
  • anandamide
Topics
  • Amides
  • Arachidonic Acids (metabolism)
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Chromatography, High Pressure Liquid
  • Colonic Neoplasms (chemistry, metabolism)
  • Endocannabinoids (analysis, genetics, metabolism)
  • Ethanolamines (analysis, metabolism)
  • Glycerides (metabolism)
  • Humans
  • Interferon-gamma (metabolism, pharmacology)
  • Ionomycin (pharmacology)
  • Palmitic Acids (metabolism)
  • Polyunsaturated Alkamides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: